Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Rivera

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
ACS Chemical Biology|November 27, 2020
Multi-Institution Research and Education Collaboration Identifies New Antimicrobial CompoundsAmelia A Fuller, Amy B Dounay, Douglas Schirch, et al.
Vaccines|November 25, 2023
Comparative Immune Response after Vaccination with SOBERANA<sup>®</sup> 02 and SOBERANA<sup>®</sup> plus Heterologous Scheme and Natural Infection in Young ChildrenRocmira Pérez-Nicado, Chiara Massa, Laura Marta Rodríguez-Noda, et al.
Proteomics|July 18, 2025
LC-MS/MS Characterization of SOBERANA 02, a Receptor Binding Domain-Tetanus Toxoid Conjugate Vaccine Against SARS-CoV-2Olivia Martínez, Darielys Santana-Medero, Satomy Pousa, et al.
Toxicology|April 1, 2022
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley ratsReynaldo Oliva-Hernández, Mildrey Fariñas-Medina, Tamara Hernández-Salazar, et al.
ACS Omega|November 26, 2019
Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal ActivityFidel E Morales Vicente, Melaine González-Garcia, Erbio Diaz Pico, et al.
Biomolecules|June 2, 2021
Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial StrainsMelaine González-García, Fidel Morales-Vicente, Erbio Díaz Pico, et al.
Analytical and Bioanalytical Chemistry|November 5, 2021
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrumLuis Ariel Espinosa, Yassel Ramos, Ivan Andújar, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Med (New York, N.Y.)|August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsMaría Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
ACS Chemical Biology|November 27, 2020
Multi-Institution Research and Education Collaboration Identifies New Antimicrobial CompoundsAmelia A Fuller, Amy B Dounay, Douglas Schirch, et al.
Vaccines|November 25, 2023
Comparative Immune Response after Vaccination with SOBERANA<sup>®</sup> 02 and SOBERANA<sup>®</sup> plus Heterologous Scheme and Natural Infection in Young ChildrenRocmira Pérez-Nicado, Chiara Massa, Laura Marta Rodríguez-Noda, et al.
Proteomics|July 18, 2025
LC-MS/MS Characterization of SOBERANA 02, a Receptor Binding Domain-Tetanus Toxoid Conjugate Vaccine Against SARS-CoV-2Olivia Martínez, Darielys Santana-Medero, Satomy Pousa, et al.
Toxicology|April 1, 2022
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley ratsReynaldo Oliva-Hernández, Mildrey Fariñas-Medina, Tamara Hernández-Salazar, et al.
ACS Omega|November 26, 2019
Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal ActivityFidel E Morales Vicente, Melaine González-Garcia, Erbio Diaz Pico, et al.
Biomolecules|June 2, 2021
Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial StrainsMelaine González-García, Fidel Morales-Vicente, Erbio Díaz Pico, et al.
Analytical and Bioanalytical Chemistry|November 5, 2021
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrumLuis Ariel Espinosa, Yassel Ramos, Ivan Andújar, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Med (New York, N.Y.)|August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsMaría Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Pageof 10